Body

Scientists identify microRNA as possible cause of chemotherapy resistance

DEAD SEA, Jordan — Scientists may have uncovered a mechanism for resistance to paclitaxel in ovarian cancer, microRNA-31, suggesting a possible therapeutic target for overcoming chemotherapy resistance.

Tumors may respond to extreme and moderate heat

DEAD SEA, Jordan — Aided by ultrasound guidance, treating tumors with extreme heat or moderate heat may provide a possible therapeutic option, according to early research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held March 7-10, 2010.

Doctors are failing to lower heart patients' cholesterol adequately

Only half of all patients at high risk of heart disease are given correct targets for lowering their cholesterol levels according to a study of 25,250 patients in Germany published online today (Thursday 11 March) in the European Heart Journal [1].

First whole genome sequencing of family of 4 reveals new genetic power

SEATTLE, WA – March 10, 2010 -- The Institute for Systems Biology (ISB) has analyzed the first whole genome sequences of a human family of four. The findings of a project funded through a partnership between ISB and the University of Luxembourg was published online today by Science on its Science Express website. It demonstrates the benefit of sequencing entire families, including lowering error rates, identifying rare genetic variants and identifying disease-linked genes.

Entire family genome sequence: parents give kids fewer gene mutations than thought

(SALT LAKE CITY)—Researchers at the University of Utah and other institutions have sequenced for the first time the entire genome of a family, enabling them to accurately estimate the average rate at which parents pass genetic mutations to their offspring and also identify precise locations where parental chromosomes exchange information that creates new combinations of genetic traits in their children.

Finding Charcot-Marie-Tooth gene ends a quest and begins new era of personalized genomic medicine

HOUSTON -- (March 10, 2010) – Baylor College of Medicine's Dr. James Lupski came to the end of a personal quest earlier this year when the Baylor Human Genome Sequencing Center (www.hgsc.bcm.tmc.edu/) sequenced his complete genome and identified the gene involved in his own form of Charcot-Marie-Tooth syndrome, which affects the function of nerves in the body's limbs, hands and feet. At the same time, the finding opened a new door showing that genome information has clinical importance.

New methods needed to ID cardiac catheterization candidates

DURHAM, NC – It's time to re-think how patients are selected for cardiac catheterization, say doctors at Duke University Medical Center, after reporting in a new study that the invasive procedure found no significant coronary artery disease in nearly 60 percent of chest pain patients with no prior heart disease.

Institute for Systems Biology uses Complete Genomics' genome sequencing service to verify gene responsible for Miller syndrome

MOUNTAIN VIEW, Calif.

Experimental drug that mimics thryoid hormone safely lowers 'bad' cholesterol

People whose "bad" cholesterol and risk of future heart disease stay too high despite cholesterol-lowering statin therapy can safely lower it by adding a drug that mimics the action of thyroid hormone. In a report published in the Mar. 11, issue of the New England Journal of Medicine, Johns Hopkins and Swedish researchers say an experimental drug called eprotirome lowered cholesterol up to 32 percent in those already on statins, an effect equal to that expected from doubling the statin drug doses, without harmful side effects.

Gastric bypass surgery increases risk of kidney stones

DALLAS – March 11, 2010 – Patients who undergo gastric bypass surgery experience changes in their urine composition that increase their risk of developing kidney stones, research from UT Southwestern Medical Center investigators suggests.

A new study, published in the March issue of The Journal of Urology, found that some of these urinary changes place weight-loss surgery patients at higher risk for developing kidney stones than obese patients who do not undergo the procedure.

The American Association of Anatomists approves guidelines for body donation programs

Bethesda, Maryland — The Board of Directors of the American Association of Anatomists (AAA) has approved a set of guidelines to govern programs accepting the donation of bodies for education and biomedical research. The guidelines cover the minimum requirements that should be met by any Willed Body Program.

New drug candidate reduces blood lipids

A thyroid-hormone-like substance that works specifically on the liver reduces blood cholesterol with no serious side effects. This according to a clinical trial conducted by researchers from the Swedish medical university Karolinska Institutet, amongst other centres, published today in the top-ranking scientific periodical The New England Journal of Medicine.

Solved: the puzzle of chickens that are half male and half female

A puzzle that has baffled scientists for centuries – why some birds appear to be male on one side of the body and female on the other – has been solved by researchers.

The research, which involved studying rare naturally occurring chickens with white (male) plumage on one side and brown (female) plumage on the other, sheds new light on the sexual development of birds.

It was previously thought that sex chromosomes in birds control whether a testis or ovary forms, with sexual traits then being determined by hormones.

Fulvestrant breast cancer drug more effective in presence of CK8 and CK18

BLOOMINGTON, Ind. -- Women's responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, Indiana University Bloomington scientists report in this month's Cancer Biology & Therapy.

Fulvestrant appeared to exert maximum anti-cancer effects in vitro when cells produced normal or elevated quantities of the cytokeratins CK8 and CK18, structural proteins that help give the nucleus its shape.

Years of smoking associated with lower Parkinson's risk, not number of cigarettes per day

ST. PAUL, Minn. – Researchers have new insight into the relationship between Parkinson's disease and smoking. Several studies have shown that smokers have a lower risk of developing Parkinson's disease. A new study published in the March 10, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology, shows that smoking for a greater number of years may reduce the risk of the disease, but smoking a larger number of cigarettes per day may not reduce the risk.